临床试验/NCT07340814

NCT07340814尚未招募不适用

A Long-term Follow-up Study of Patients Who Received MB-105

March Biosciences Inc0 个研究点目标入组 40 人开始时间: 2026年2月27日最近更新: 2026年1月14日

干预措施

试验速览

阶段: 不适用
状态: 尚未招募
发起方: March Biosciences Inc
入组人数: 40
主要终点: Assess long term safety of MB-105 in patients who received MB-105

研究概览研究设计入排标准研究组 & 干预措施结局指标研究者记录与标识符相似试验

研究概览

简要总结

This study is to fulfil the regulatory requirement for 15-year follow-up for patients treated with MB-105 in any study

详细描述

This study is for long term follow up of efficacy and safety for any patient treated with MB-105 who has consented to joining the LTFU study. There are no exclusion criteria.

研究设计

研究类型: Observational
观察模型: Cohort
时间视角: Prospective

入排标准

年龄范围: 18 Years 至 —（Adult, Older Adult）
性别: All
接受健康志愿者: 否

入选标准

•Received MB-105 Signed informed consent Agree to transfer of samples from previous study Able to comply with study requirements

排除标准

未提供

研究组 & 干预措施

Open Observation

All patients who previously received MB-105 on another study

干预措施: MB-105 (Biological)

结局指标

主要结局

Assess long term safety of MB-105 in patients who received MB-105

时间窗: 15 Years

SAEs

次要结局

Assess long term efficacy of MB-105 in patients who received MB-105(15 Years)

研究者

发起方

March Biosciences Inc

申办方类型

Industry

责任方

Sponsor

相似试验

招募中

2 期

Phase II multicentric study: efficacy evaluation of neo-adjuvant treatment associated with maintenance therapy by anti-PD1 immunotherapy on disease-free-survival (DFS) in patients with resectable mucosal melanoma

2024-513027-16-00Institut Gustave Roussy60

尚未招募

1 期

A Phase I/II Study to Evaluate XNW34017 in Patients With Advanced or Metastatic Solid Tumor

NCT07327294Evopoint Biosciences Inc.150

招募中

2 期

Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy (MecMeth/ NOA-24)Glioblastoma

2024-511264-89-00Rheinische Friedrich-Wilhelms-Universitaet Bonn72

尚未招募

3 期

Innovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant Tuberculosis：BLMZ Chinese CohortPulmonary TuberculosisTuberculosisDrug-resistant Tuberculosis

NCT07268664Beijing Chest Hospital120

终止

不适用

A Study to Describe the Real-world Effectiveness, Safety and Patterns of Use of Dupilumab in Patients With Chronic Spontaneous Urticaria

NCT07316114Sanofi1